New modes of data partitioning based on PARS peak alignment for improved multivariate biomarker/biopattern detection in 1H-NMR spectroscopic metabolic profiling of urine

被引:17
作者
Torgrip, R. J. O.
Lindberg, J.
Linder, M.
Karlberg, B.
Jacobsson, S. P.
Kolmert, J.
Gustafsson, I.
Schuppe-Koistinen, I.
机构
[1] AstraZeneca R&D Sodertalje, Safety Assessment, Mol Toxicol, SE-15185 Sodertalje, Sweden
[2] AstraZeneca Sodertalje, PAR&D, SE-15185 Sodertalje, Sweden
[3] AstraZeneca R&D Sodertalje, Stat Sci, SE-15185 Sodertalje, Sweden
关键词
urine; biofluid; H-1-NMR; peak alignment; multivariate; metabolic profiling; hepatic steatosis;
D O I
10.1007/s11306-005-0013-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper addresses the possibility of mathematically partition and process urine H-1-NMR spectra to enhance the efficiency of the subsequent multivariate data analysis in the context of metabolic profiling of a toxicity study. We show that by processing the NMR data with the peak alignment using reduced set mapping (PARS) algorithm and the use of sparse representation of the data results in the information contained in the original NMR data being preserved with retained resolution but free of the problem of peak shifts. We can now describe a method for differential expression analysis of NMR spectra by using prior knowledge, i.e., the onset of dosing, a partitioning not possible to achieve using raw or bucketed data. In addition we also outline a scheme for soft removal of "biological noise" from the aligned data: exhaustive bio-noise subtraction (EBS). The result is a straightforward protocol for detection of peaks that appear as a consequence of the drug response. In other words, it is possible to elucidate peak origin, either from endogenous substances or from the administered drug/biomarkers. The partition of data originating from the normally regulating metabolome can, furthermore, be analyzed free of the Superimposed biological noise. The proposed protocol results in enhanced interpretability of the processed data, i.e., a more refined metabolic trace, simplification of detection of consistent biomarkers, and a simplified search for metabolic end products of the administered drug.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 24 条
  • [1] ABERG M, 2005, J CHEMOMETR, V19, P1
  • [2] Preprocessing peptide sequences for multivariate sequence-property analysis
    Andersson, PM
    Sjostrom, M
    Lundstedt, T
    [J]. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1998, 42 (1-2) : 41 - 50
  • [3] Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution 1H NMR spectroscopy of urine and pattern recognition
    Bollard, ME
    Holmes, E
    Lindon, JC
    Mitchell, SC
    Branstetter, D
    Zhang, W
    Nicholson, JK
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 295 (02) : 194 - 202
  • [4] PARAFAC. Tutorial and applications
    Bro, R
    [J]. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1997, 38 (02) : 149 - 171
  • [5] NMR spectral quantitation by principal-component analysis .2. Determination of frequency and phase shifts
    Brown, TR
    Stoyanova, R
    [J]. JOURNAL OF MAGNETIC RESONANCE SERIES B, 1996, 112 (01): : 32 - 43
  • [6] Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies
    Cloarec, O
    Dumas, ME
    Trygg, J
    Craig, A
    Barton, RH
    Lindon, JC
    Nicholson, JK
    Holmes, E
    [J]. ANALYTICAL CHEMISTRY, 2005, 77 (02) : 517 - 526
  • [7] Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats:: implications for biomarker discovery
    Connor, SC
    Wu, W
    Sweatman, BC
    Manini, J
    Haselden, JN
    Crowther, DJ
    Waterfield, CJ
    [J]. BIOMARKERS, 2004, 9 (02) : 156 - 179
  • [8] Multiway chemometric analysis of the metabolic response to toxins monitored by NMR
    Dyrby, M
    Baunsgaard, D
    Bro, R
    Engelsen, SB
    [J]. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2005, 76 (01) : 79 - 89
  • [9] EBBELS T, 2002, Patent No. 2002052293
  • [10] Farber E, 1967, Adv Lipid Res, V5, P119